FilingReader Intelligence

Baiyunshan Pharma announces further details on Baiyunshan Bio capital increase

June 16, 2025 at 05:14 PM UTCBy FilingReader AI

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (SSE:600332) has released a further announcement pertaining to its related transaction involving a capital increase to Baiyunshan Biopharmaceuticals. This follows their initial announcement made on May 28, 2025. The announcement includes details regarding the profit forecast related to the transaction, which was previously classified as a profit forecast under Rule 14.61 of the Listing Rules.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Guangzhou Baiyunshan Pharmaceutical Holdings publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →